Skip to Content
Merck
  • A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).

A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).

Mechanisms of development (2006-02-07)
Jianmin Liu, Sherry L Ball, Yuan Yang, Pinchao Mei, Lei Zhang, Haining Shi, Henry J Kaminski, Vance P Lemmon, Huaiyu Hu
ABSTRACT

Protein O-mannose beta1,2-N-acetyglucosaminyltransferase 1 (POMGnT1) is an enzyme involved in the synthesis of O-mannosyl glycans. Mutations of POMGnT1 in humans result in the muscle-eye-brain (MEB) disease. In this study, we have characterized a null mutation generated by gene trapping with a retroviral vector inserted into the second exon of the mouse POMGnT1 locus. Expression of POMGnT1 mRNA was abolished in mutant mice. Glycosylation of alpha-dystroglycan was also reduced. POMGnT1 mutant mice were viable with multiple developmental defects in muscle, eye, and brain, similar to the phenotypes observed in human MEB disease. The present study provides the first genetic animal model to further dissect the roles of POMGnT1 in MEB disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-α-Dystroglycan Antibody, clone VIA4-1, culture supernatant, clone VIA4-1, Upstate®